...
首页> 外文期刊>ChemMedChem >Synthesis of N-Aryl- and N-alkyl-Substituted Imidazolium Silver Complexes: Cytotoxic Screening by Using Human Cell Lines Modelling Acute Myeloid Leukaemia
【24h】

Synthesis of N-Aryl- and N-alkyl-Substituted Imidazolium Silver Complexes: Cytotoxic Screening by Using Human Cell Lines Modelling Acute Myeloid Leukaemia

机译:合成N-芳基和N-烷基取代的咪唑鎓银络合物:通过使用人细胞系对急性髓性白血病进行构建的细胞毒性筛选

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of N-aryl- and N-alkyl substituted imidazoles has been synthesised and complexed with Ag+ to obtain silver-NHC complexes of the form [Ag(NHC)2]X. These silver-NHC complexes were tested in vitro against the human cell lines HL-60 and MOLM-13, which both model acute myeloid leukaemia (AML). A substantial difference in cytotoxicity was revealed varying in the range 13-4 μM and 22-9 μM for HL-60 and MOLM-13, respectively. Furthermore, this study revealed that when an alkyl group is installed on the imidazole scaffold, its position substantially influences the cytotoxicity of the corresponding silver NHC complex.
机译:已经合成了一系列的N-芳基和N-烷基取代的咪唑并用Ag +络合,得到形式[Ag(NHC)2] X的银 - NHC络合物。 将这些银NHC复合物对人体细胞系HL-60和MOLM-13进行测试,其模型急性髓性白血病(AML)。 对于HL-60和MOLM-13,分别在13-4μm和22-9μm的范围内揭示了细胞毒性的显着差异。 此外,该研究表明,当将烷基安装在咪唑支架上时,其位置基本上影响相应的银NHC络合物的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号